Related references
Note: Only part of the references are listed.Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
Lorenzo Barba et al.
MOVEMENT DISORDERS (2022)
Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice
Ruben Pavia-Collado et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins
Kathryn E. Carnazza et al.
CELL REPORTS (2022)
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
Lluis Miquel-Rio et al.
TRANSLATIONAL PSYCHIATRY (2022)
Dopamine promotes the neurodegenerative potential of β-synuclein
Anupam Raina et al.
JOURNAL OF NEUROCHEMISTRY (2021)
L-DOPA regulates α-synuclein accumulation in experimental parkinsonism
Marc Deffains et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins
Natalia Ninkina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease
Benjamin Huynh et al.
MOVEMENT DISORDERS (2021)
Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease
Christopher E. J. Doppler et al.
BRAIN (2021)
Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease
Jannik Prasuhn et al.
NEUROLOGY (2021)
Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease
Jannik Prasuhn et al.
NEUROLOGY (2021)
alpha-Synuclein strains target distinct brain regions and cell types
Angus Lau et al.
NATURE NEUROSCIENCE (2020)
Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys
Mathilde Millot et al.
NEUROBIOLOGY OF DISEASE (2020)
Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys
Xuran Li et al.
NEUROSCIENCE LETTERS (2020)
Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease
Nicole Elaine Chambers et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Noradrenergic System in Parkinson's Disease
Elena Paredes-Rodriguez et al.
FRONTIERS IN PHARMACOLOGY (2020)
α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys
Scott C. Vermilyea et al.
CELL TRANSPLANTATION (2019)
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Sarah H. Shahmoradian et al.
NATURE NEUROSCIENCE (2019)
Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders
Allison J. Schaser et al.
SCIENTIFIC REPORTS (2019)
Normal and pathological neuronal distribution of the human mesencephalic locomotor region
Sophie B. Sebille et al.
MOVEMENT DISORDERS (2019)
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease
Maria Nguyen et al.
TRENDS IN NEUROSCIENCES (2019)
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease
Gunasingh J. Masilamoni et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Diffusion Tensor Imaging Marks Dopaminergic and Serotonergic Lesions in the Parkinsonian Monkey
Elise Metereau et al.
MOVEMENT DISORDERS (2018)
Phosphorylated alpha-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP
Baihui Huang et al.
NEUROSCIENCE (2018)
Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies
Ana Gamez-Valero et al.
GENES (2018)
The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene
Viktor S. Kokhan et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2018)
Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates
Maude Beaudoin-Gobert et al.
NEUROIMAGE (2018)
Neurodegeneration and the ordered assembly of α-synuclein
Maria Grazia Spillantini et al.
CELL AND TISSUE RESEARCH (2018)
The two-century journey of Parkinson disease research
Serge Przedborski
NATURE REVIEWS NEUROSCIENCE (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys
Gunasingh Jeyaraj Masilamoni et al.
NEUROBIOLOGY OF DISEASE (2017)
Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys
D. Gagnon et al.
BRAIN STRUCTURE & FUNCTION (2016)
Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease
Manale Bensaid et al.
EXPERIMENTAL NEUROLOGY (2016)
Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer's and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
Patrick Oeckl et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism
Natalie Connor-Robson et al.
NEUROBIOLOGY OF AGING (2016)
Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques
Katsuo Kimura et al.
PLOS ONE (2016)
Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate
Maude Beaudoin-Gobert et al.
BRAIN (2015)
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease
Janina Deusser et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
Benjamin Dehay et al.
LANCET NEUROLOGY (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies
Kay Seidel et al.
BRAIN PATHOLOGY (2015)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Stage-Dependent Nigral Neuronal Loss in Incidental Lewy Body and Parkinson's Disease
Anke A. Dijkstra et al.
MOVEMENT DISORDERS (2014)
Neuroimaging in Parkinson disease: from research setting to clinical practice
Marios Politis
NATURE REVIEWS NEUROLOGY (2014)
Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Benjamin G. Wilhelm et al.
SCIENCE (2014)
New alpha- and gamma-synuclein immunopathological lesions in human brain
Irina Surgucheva et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
β-Synuclein Aggregates and Induces Neurodegeneration in Dopaminergic Neurons
Grit Taschenberger et al.
ANNALS OF NEUROLOGY (2013)
Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice
Viktor S. Kokhan et al.
BMC NEUROSCIENCE (2013)
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease
Daniel Garcia-Lorenzo et al.
BRAIN (2013)
Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia
Kelly Del Tredici et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys
Gunasingh J. Masilamoni et al.
BRAIN (2011)
Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease
Pamela J. McMillan et al.
BRAIN RESEARCH (2011)
Synuclein modulation of monoamine transporters
Adam W. Oaks et al.
FEBS LETTERS (2011)
Alpha- and beta-synuclein expression in Parkinson disease with and without dementia
Katrin Beyer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease
Carine Karachi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Jacqueline Burre et al.
SCIENCE (2010)
Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation
Tultul Nayyar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
γ-Synucleinopathy: neurodegeneration associated with overexpression of the mouse protein
Natalia Ninkina et al.
HUMAN MOLECULAR GENETICS (2009)
No Lewy Pathology in Monkeys with Over 10 Years of Severe MPTP Parkinsonism
Glenda Halliday et al.
MOVEMENT DISORDERS (2009)
Pathologic modifications of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -: Treated squirrel monkeys
Alison L. McCormack et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients
Juha O. Rinne et al.
PARKINSONISM & RELATED DISORDERS (2008)
The Lewy body in Parkinson's disease:: Molecules implicated in the formation and degradation of α-synuclein aggregates
Koichi Wakabayashi et al.
NEUROPATHOLOGY (2007)
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2007)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra
Fumiaki Mori et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
α-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
MG Purisai et al.
NEUROBIOLOGY OF DISEASE (2005)
α-synuclein locus duplication as a cause of familial Parkinson's disease
MC Chartier-Harlin et al.
LANCET (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
Biophysical properties of the synucleins and their propensities to fibrillate -: Inhibition of α-synuclein assembly by β- and γ-synucleins
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
NW Kowall et al.
NEUROREPORT (2000)
The pedunculopontine nucleus and Parkinson's disease
PA Pahapill et al.
BRAIN (2000)
Share Paper
